351 related articles for article (PubMed ID: 29403272)
1. Impact of using the new GOLD classification on the distribution of COPD severity in clinical practice.
Hernández M; García G; Falco J; García AR; Martín V; Ibarrola M; Quadrelli S
Int J Chron Obstruct Pulmon Dis; 2018; 13():351-356. PubMed ID: 29403272
[TBL] [Abstract][Full Text] [Related]
2. Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.
Mapel DW; Dalal AA; Johnson PT; Becker LK; Hunter AG
Int J Chron Obstruct Pulmon Dis; 2015; 10():1477-86. PubMed ID: 26251587
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013.
Raluy-Callado M; Lambrelli D; MacLachlan S; Khalid JM
Int J Chron Obstruct Pulmon Dis; 2015; 10():925-37. PubMed ID: 25999708
[TBL] [Abstract][Full Text] [Related]
4. The distribution of COPD in UK general practice using the new GOLD classification.
Haughney J; Gruffydd-Jones K; Roberts J; Lee AJ; Hardwell A; McGarvey L
Eur Respir J; 2014 Apr; 43(4):993-1002. PubMed ID: 24176990
[TBL] [Abstract][Full Text] [Related]
5. 2017 Global Initiative for Chronic Obstructive Lung Disease reclassifies half of COPD subjects to lower risk group.
Högman M; Sulku J; Ställberg B; Janson C; Bröms K; Hedenström H; Lisspers K; Malinovschi A
Int J Chron Obstruct Pulmon Dis; 2018; 13():165-173. PubMed ID: 29379281
[TBL] [Abstract][Full Text] [Related]
6. GOLD Classification of COPD: Discordance in Criteria for Symptoms and Exacerbation Risk Assessment.
Mittal R; Chhabra SK
COPD; 2017 Feb; 14(1):1-6. PubMed ID: 27723367
[TBL] [Abstract][Full Text] [Related]
7. The PLATINO study: description of the distribution, stability, and mortality according to the Global Initiative for Chronic Obstructive Lung Disease classification from 2007 to 2017.
Menezes AM; Wehrmeister FC; Perez-Padilla R; Viana KP; Soares C; Müllerova H; Valdivia G; Jardim JR; Montes de Oca M
Int J Chron Obstruct Pulmon Dis; 2017; 12():1491-1501. PubMed ID: 28553101
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of Patients with Chronic Obstructive Pulmonary Disease at the First Visit to a Pulmonary Medical Center in Korea: The KOrea COpd Subgroup Study Team Cohort.
Lee JY; Chon GR; Rhee CK; Kim DK; Yoon HK; Lee JH; Yoo KH; Lee SH; Lee SY; Kim TE; Kim TH; Park YB; Hwang YI; Kim YS; Jung KS
J Korean Med Sci; 2016 Apr; 31(4):553-60. PubMed ID: 27051239
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of a COPD population categorised using the GOLD framework by health status and exacerbations.
Jones PW; Nadeau G; Small M; Adamek L
Respir Med; 2014 Jan; 108(1):129-35. PubMed ID: 24041746
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.
Kawamatawong T; Onnipa J; Suwatanapongched T
Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516
[TBL] [Abstract][Full Text] [Related]
11. GOLD assessment of COPD severity in the Clinical Practice Research Datalink (CPRD).
Rebordosa C; Plana E; Aguado J; Thomas S; García-Gil E; Perez-Gutthann S; Castellsague J
Pharmacoepidemiol Drug Saf; 2019 Feb; 28(2):126-133. PubMed ID: 29740896
[TBL] [Abstract][Full Text] [Related]
12. The effect of comorbidities on COPD assessment: a pilot study.
Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
[TBL] [Abstract][Full Text] [Related]
13. Peak expiratory flow rate as a surrogate for forced expiratory volume in 1 second in COPD severity classification in Thailand.
Pothirat C; Chaiwong W; Phetsuk N; Liwsrisakun C; Bumroongkit C; Deesomchok A; Theerakittikul T; Limsukon A
Int J Chron Obstruct Pulmon Dis; 2015; 10():1213-8. PubMed ID: 26150713
[TBL] [Abstract][Full Text] [Related]
14. Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claims.
Mapel DW; Dalal AA; Blanchette CM; Petersen H; Ferguson GT
Int J Chron Obstruct Pulmon Dis; 2011; 6():573-81. PubMed ID: 22135490
[TBL] [Abstract][Full Text] [Related]
15. Comorbidity in chronic obstructive pulmonary disease. Related to disease severity?
Echave-Sustaeta JM; Comeche Casanova L; Cosio BG; Soler-Cataluña JJ; Garcia-Lujan R; Ribera X
Int J Chron Obstruct Pulmon Dis; 2014; 9():1307-14. PubMed ID: 25429213
[TBL] [Abstract][Full Text] [Related]
16. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
[TBL] [Abstract][Full Text] [Related]
17. Stratification of patients with COPD according to the 2011 GOLD report.
Grzelewska-Rzymowska I; Patora-Mikołajczyk J; Górski P
Pneumonol Alergol Pol; 2014; 82(5):415-21. PubMed ID: 25133809
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a claims-based prediction model for COPD severity.
Macaulay D; Sun SX; Sorg RA; Yan SY; De G; Wu EQ; Simonelli PF
Respir Med; 2013 Oct; 107(10):1568-77. PubMed ID: 23806285
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of COPD patients according to GOLD classification and clinical phenotypes in the Russian Federation: the SUPPORT trial.
Arkhipov V; Arkhipova D; Miravitlles M; Lazarev A; Stukalina E
Int J Chron Obstruct Pulmon Dis; 2017; 12():3255-3262. PubMed ID: 29138554
[TBL] [Abstract][Full Text] [Related]
20. Discrepancies between modified Medical Research Council dyspnea score and COPD assessment test score in patients with COPD.
Rhee CK; Kim JW; Hwang YI; Lee JH; Jung KS; Lee MG; Yoo KH; Lee SH; Shin KC; Yoon HK
Int J Chron Obstruct Pulmon Dis; 2015; 10():1623-31. PubMed ID: 26316736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
